Total Funding
24
Total FundingSeries D raised
Growth Score
pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
118499
NeoSync, Inc. is a clinical stage company That treatment of Major Depressive Disorder.
Lawrence C. Best: Chairman
About the Company
NeoSync is a clinical-stage company with a proprietary platform technology being used to develop advanced, non-invasive neuromodulation products designed to treat Major Depressive Disorder and other diseases of the Central Nervous System .(Autism, Parkinson's Disease, Anxiety, Post Traumatic Stress Disorder, etc.). The Company is led by
experienced medical device executives and entrepreneurs.
